LEADER 03386nam  2200493   450 
001 9910220527703321
005 20230725020318.0
035   $a(CKB)3810000000214004
035   $a(EXLCZ)993810000000214004
100   $a20171016d2011      uy             0
101 0 $aeng
135   $aurcn#nnn|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMarkets and public values in healthcare /$fTeun Zuiderent-Jerak, Kor Grit and Tom Van der Grindten
210  1$aThe Hague :$cWetenschappelijke Raad voor het Regeringsbelieid,$d2011.
215   $a1 online resource (59 pages) $cillustrations (some colour)
225 0 $aOpen Access e-Books
225 0 $aKnowledge Unlatched
225 1 $aWebpublications ;$v57
300   $a"January 2011"
320   $aIncludes bibliographical references.
327   $a1. Introduction: resisting rhetoric and opening the black box of healtcare markets -- 2. Studying markets and public values in the making -- 3. Diagnosis-treatment combinations and markets for hospital care -- 4. Care-load packages and long-term care -- 5. Conclusions on making markets for public values.
330 3 $aDiscussions on the role of markets in healthcare easily lead to political and unfruitful polarized positions. Actors arguing in favour of markets as a solution for the quality/cost conundrum entrench themselves against others pointing out the risk of markets for the delivery and governance of healthcare. These binary options of more or less marketization preclude a more empirical analysis of how markets, as multiple arrangements, are constructed and what their consequences are for public values like affordability and quality. This paper explores the empirically relationship between markets and public values in healthcare by analyzing the construction of a market for hospital care in the Netherlands, based on a system of diagnosiss-treatment combinations (DBCs), and the development of a market for long term care based on care-load packages (ZZPs). In both cases we address the intended result of care markets according to various policy actors, the visible and invisible work done by various actors to make markets work, and the values enacted in market practices. Whereas the policy aims within these markets focus on providing choice and increasing diversity of care institutions, we show that DBCs and ZZPs produce isomorphism and homogenization instead. Furthermore, the strong influence of financial instruments in shaping healthcare markets assume that cost and quality can be improved, whereas in fact these financial instruments have a profound influence on how public values like quality get defined in practice.
410  0$aWebpublications ;$v57.
606   $aHealth care$xMarketing
606   $aMedical care$xMarketing
606   $aMedical economics
606   $aMedical policy
615  0$aHealth care$xMarketing.
615  0$aMedical care$xMarketing.
615  0$aMedical economics.
615  0$aMedical policy.
676   $a362.1
700   $aZuiderent-Jerak$b Teun$0907980
702   $aGrit$b Kor$g(Kornelius Jan),$f1962-,
702   $aGrinten$b Tom van der$f1942-,
801  0$bAuAdUSA
801  1$bAuAdUSA
906   $aBOOK
912   $a9910220527703321
996   $aMarkets and public values in healthcare$92108141
997   $aUNINA